Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, Elisabeth Brouwer, Lorenzo Dagna, Bhaskar Dasgupta, Bernhard Hellmich, Eamonn Molloy, Carlo Salvarani, Bruce C Trapnell, Kenneth J Warrington, Ian Wicks, Manoj Samant, Teresa Zhou, Lara PupimSee the full list of authors
9 March 2022
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritisMarc Corbera-Bellalta, Roser Alba-Rovira, Sujatha Muralidharan, Georgina Espígol-Frigolé, Roberto Ríos-Garcés, Javier Marco-Hernández, Amanda Denuc, Farah Kamberovic, Patricia Pérez-Galán, Alexandra Joseph, Annalisa D’Andrea, Kent Bondensgaard, Maria C Cid, John F Paolini
19 January 2022
Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritisIgnatius Ryan Adriawan, Faranaz Atschekzei, Oliver Dittrich-Breiholz, Panagiotis Garantziotis, Stefanie Hirsch, Linus Maximillian Risser, Maike Kosanke, Reinhold Ernst Schmidt, Torsten Witte, Georgios Sogkas
28 September 2021
Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational studyXiufang Kong, Ying Sun, Xiaojuan Dai, Li Wang, Zongfei Ji, Huiyong Chen, Xuejuan Jin, Lili Ma, Lindi Jiang
6 August 2021
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysisCristina Ponte, Sara Monti, Carlo Alberto Scirè, Paolo Delvino, Nikita Khmelinskii, Alessandra Milanesi, Vítor Teixeira, Fabio Brandolino, Fernando Saraiva, Carlomaurizio Montecucco, João Eurico Fonseca, Wolfgang A Schmidt, Raashid Ahmed Luqmani
2 July 2021
Treatment failure in giant cell arteritisSebastian H Unizony, Min Bao, Jian Han, Yves Luder, Andrey Pavlov, John H Stone
28 May 2021
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Aljayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Lindsy Forbess, Shouichi FujimotoSee the full list of authors
24 June 2020
Targeting JAK/STAT pathway in Takayasu’s arteritisPaul Régnier, Alexandre Le Joncour, Anna Maciejewski-Duval, Anne-Claire Desbois, Cloé Comarmond, Michelle Rosenzwajg, David Klatzmann, Patrice Cacoub, David Saadoun
25 March 2020
Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritisDespina Michailidou, Joel S Rosenblum, Casey A Rimland, Jamie Marko, Mark A Ahlman, Peter C Grayson
24 October 2019
Takayasu arteritis risk locus in IL6 represses the anti-inflammatory gene GPNMB through chromatin looping and recruiting MEF2–HDAC complexXiufang Kong, Amr H Sawalha
17 July 2019
